Category: Devices

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Violet Rodriguez

Lignocellulosic biomass is a flexible renewable useful resource for fuels, buildings, crafts, and biomaterials. Strategies of molecularly designing lignocellulose for industrial software has been developed by the discoveries of novel genes after the screenings of varied mutants and remodeled traces of Arabidopsis whose cell partitions might be modified in the inflorescence stem, a mannequin woody tissue. The mechanical properties are used as a quantitative index for the chemorehological conduct of the genetically modified cell wall in the tissue.

This parameter could be measured with tensile or bending checks of tissue explants, the vibration evaluation of tissue conduct or utilizing atomic power microscopy to probe the tissue floor. Here, we describe in element the process to find out the stiffness of methanol-fixed, rehydrated and pronase-treated inflorescence explants with a tensile testing machine primarily based on classical strategies for the dedication of cell wall extensibility.

Extracellular matrix (ECM)-based tissue engineering scaffolds have a necessary position in selling tissue regeneration. Nerve tissue engineering goals at facilitating the restore of everlasting injury to the peripheral and central nervous methods, that are tough to heal. For this function, a range of biomaterials are being developed consisting of quite a few artificial and/or pure polymers to offer axonal reinnervation and to direct the development of axons. Here, we current a novel protocol that permits to manufacture a three-d (3D) decellularized scaffold derived from the bovine spinal twine (BSC) ECM (3D-dCBS) for neural tissue engineering purposes.

In this protocol, a viscous ECM-derived gel from BSC is ready, molded, and chemically crosslinked with EDC/NHS (3D-CBS) earlier than decellularization course of. Decellularization of 3D-CBS is carried out with 1% SDS to realize 3D-dCBS. As in contrast with different out there strategies, our protocol is a novel decellularization technique that preserves a extra important half of the ECM. We imagine that the talked about protocol has the potential to supply a bioengineered scaffold from spinal twine tissue with desired geometry for regenerative drugs purposes associated to neural tissue engineering.

The Fabrication of Poly( Σ-caprolactone)-Poly(ethylene oxide) Sandwich Type Nanofibers Containing Sericin-Capped Silver Nanoparticles as an Antibacterial Wound Dressing

In this examine, antibacterial, artificial poly(Σ-caprolactone)-poly(ethylene oxide) (PCL-PEO) multilayer nanofibers had been produced by an electrospinning technique. The materials was synthesized in Three layers. The upper-lower protecting layers had been produced by PCL nanofibers and the intermediate layer was produced from PEO nanofiber containing sericin-capped silver nanoparticles (S-AgNPs). The electrospinning circumstances in which nano-sized, clean, bead-free fibers had been obtained was decided to be an utilized voltage of 20 kV, a circulate price of 8 μL/min and a distance between the collector and the needle tip of 22 cm for the PCL layer (dissolved at a 12% g/mL focus in a chloroform:methanol (3:2) solvent combination) layer.

For the S-AgNPs doped PEO layer (dissolved at a 3.5% g/mL focus in water), the corresponding circumstances had been decided to be 20 kV, 15 μL/min and 20 cm.To characterize the three-layer materials that consisted of PCL and S-AgNPs doped PEO layers, FTIR and SEM analyses had been carried out, and the water retention capability, in situ degradability and antibacterial exercise of the materials was investigated.

According to SEM evaluation, the fibers obtained had been discovered to be nano-sized, clean and bead-free and the common measurement of the nanofibers forming the PCL layer was 687 nm whereas the common measurement of the fibers forming the PEO layer was 98 nm. Antibacterial exercise checks had been carried out utilizing gram-positive (Staphylococcus aureus ATCC 6538) and gram-negative (Escherichia coli ATCC 25922) micro organism and the ensuing biomaterial was discovered to have antimicrobial impact on each gram-negative and gram-positive micro organism. It was decided that the 3-layer materials obtained in this examine can be utilized as a wound dressing.

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Peptide-Chitosan Engineered Scaffolds for Biomedical Applications

Peptides are signaling epitopes that management many important organic occasions. Increased specificity, artificial feasibility with concomitant lack of toxicity, and immunogenicity make this rising class of biomolecules appropriate for totally different purposes together with therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of d-glucosamine and N-acetyl-d-glucosamine items, possesses anti-microbial, muco-adhesive, and hemostatic properties together with wonderful biocompatibility.

As a end result, chitosan finds software in drug/gene supply, tissue engineering, and bioimaging. Despite these purposes, chitosan demonstrates restricted cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a brand new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a end result, current research embody elevated software of peptide-chitosan hybrids as composites or conjugates in drug supply, cell remedy, and tissue engineering and as anti-microbial materials. This evaluate discusses the current investigations involving chitosan-peptide supplies and uncovers varied facets of these attention-grabbing hybrid supplies for biomedical purposes.

CAR negative control: Anti-CD19-ScFv-4-1BB (Puro)
CAR-ctr2 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: Anti-CD19 (4-1BB) control lentivirus without activation domain, containing Puromycin selection

Anti-CD40 [A54 scFv]
MBS488460-02mg 0.2mg
EUR 520

Anti-CD40 [A54 scFv]
MBS488460-5x02mg 5x0.2mg
EUR 2160

2019-nCoV scFv antibody
PAab11133-1 100ug
EUR 3500

Recombinant Anti p53 scFv
MBS140082-0002mg 0.002mg
EUR 240

Recombinant Anti p53 scFv
MBS140082-001mg 0.01mg
EUR 310

Recombinant Anti p53 scFv
MBS140082-1mg 1mg
EUR 5575

Recombinant Anti p53 scFv
MBS140082-5x1mg 5x1mg
EUR 24755

Tetanus Toxoid scFv Antibody
abx137499-100tests 100 tests
EUR 225

Anti-Cardiac Troponin I [scFv 180]
MBS488422-02mg 0.2mg
EUR 520

Anti-Cardiac Troponin I [scFv 180]
MBS488422-5x02mg 5x0.2mg
EUR 2160

Anti-Cardiac Troponin I [scFv 180]
MBS488423-02mg 0.2mg
EUR 520

Anti-Cardiac Troponin I [scFv 180]
MBS488423-5x02mg 5x0.2mg
EUR 2160

Anti-FMC63 scFv Monoclonal Antibody
TRI-AB-020 0.1mg
EUR 1620

Recombinant Anti-Tetanus Toxoid scFv
MBS140085-0002mg 0.002mg
EUR 240

Recombinant Anti-Tetanus Toxoid scFv
MBS140085-001mg 0.01mg
EUR 310

Recombinant Anti-Tetanus Toxoid scFv
MBS140085-1mg 1mg
EUR 5575

Recombinant Anti-Tetanus Toxoid scFv
MBS140085-5x1mg 5x1mg
EUR 24755

FMC63 scFv, His Tag (SPR verified)
CD9-M52Hb 100ug
EUR 1515.1
Description: FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

2019-nCoV scFv antibody (S protein)
PAab11133 100ug
EUR 450

Recombinant (E.Coli) Anti-p53 scFv IgG
RP-341 10 ug
EUR 343.2

Recombinant anti-2019-nCoV NP ScFv
E21-A028-1 2019-nCoV-ScFv-Antibody
EUR 416.5
Description: 2019-nCoV ScFv Antibody

Recombinant anti-2019-nCoV NP ScFv
MBS8574824-005mg 0.05mg
EUR 705

Recombinant anti-2019-nCoV NP ScFv
MBS8574824-5x005mg 5x0.05mg
EUR 2910

P53 scFv Recombinant Antibody (p53 antibody)
PT_41676
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 0.2 mg
  • 0.5 mg

Control-1
55010021 1 Bottle Ask for price
Description: 1 bottle, Quality Control-Level 1 (dry powder 0.1ml)

Control-2
55010022 1 Bottle Ask for price
Description: 1 bottle, Quality Control-Level 2 (dry powder 0.1ml)

pHrdSV40- scFv- GCN4- sfGFP- VP64- GB1- NLS
PVT10950 2 ug
EUR 361.2

Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC
ADC-W-354 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (clone Ki4) conjugated via a linker to a MAP

LC Control
A24 -
EUR 588.6
Description: SW module for HPLC/CE control (pump, det, etc.)

AS Control
A26 -
EUR 307.8
Description: SW module for AS control

Rat neurofascin (Nfasc)-control Control/blocking peptide
AB-23249-CP 100ug
EUR 196.8

Rat Control
DEV99RC 2 x 1 ml
EUR 60

MDP control
tlrl-mdpcl 5 mg
EUR 148.05

BMP4 Control
MBS542571-5Applications 5Applications
EUR 335

BMP4 Control
MBS542571-5x5Applications 5x5Applications
EUR 1350

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 242.4

NPY1R Control
MBS543000-5Applications 5Applications
EUR 335

NPY1R Control
MBS543000-5x5Applications 5x5Applications
EUR 1350

ADCY3 Control
MBS543023-5Applications 5Applications
EUR 335

ADCY3 Control
MBS543023-5x5Applications 5x5Applications
EUR 1350

pMD18- Control
PVT10563 2 ug
EUR 319.2

pMD19- Control
PVT10564 2 ug
EUR 319.2

pGIPZ control
PVTY00348 2ug
EUR 280

Control (Zecen)
55010024 2 Bottles Ask for price
Description: Liquid form, 2 bottles (level 1: 0.1ml & level 2: 0.1ml)

Rat IgG-HRP conjugate (isotype control) (Isotype control)
20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)
20005-F 100 ug
EUR 196.8

Control Slides
24012-1 1box
EUR 64.8

Dengue Control
ant-543 100µg
EUR 165
Description: Mouse Anti-Dengue Control for Lateral Flow Test

Canine Control
DEV99CC 2 x 1 ml
EUR 60

Canine Control
MBS495203-1Set 1Set
EUR 305

Canine Control
MBS495203-5x1Set 5x1Set
EUR 1390

pTRIPZ control
PVTY00369 2ug
EUR 280

Control for ER, 4 cases (1.5mm) HumanBreastBreastIHC control
ERC081 1
EUR 50

Control for PR, 3 cases (1.5mm) HumanBreastBreastIHC control
PRC061 1
EUR 50

Rat IgG-Biotin conjugate (isotype control) (Isotype control)
20005-B 100 ug
EUR 196.8

Quality Control
abx098966-1vial 1 vial
EUR 360

Ascites, Control
MBS652640-10mL 10mL
EUR 415

Ascites, Control
MBS652640-1mL 1mL
EUR 190

Ascites, Control
MBS652640-5x10mL 5x10mL
EUR 1710

Control for HER2, 4 cases (1.5mm) HumanBreastBreastIHC control
HRC081 1
EUR 50

Goat IgG (-ve control for flow cytometry) (isotype control)
20011-100 100 test
EUR 123.6

Negative Control
MBS2568128-1mL 1mL
EUR 140

Negative Control
MBS2568129-1mL 1mL
EUR 135

Positive Control
MBS2568130-1mL 1mL
EUR 150

Positive Control
MBS2568131-1mL 1mL
EUR 150

PIPET CONTROLLER CONTROL BOARD
357484 1/pk
EUR 104.4
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories

Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control
TYROSIN081 1.5mm
EUR 50

Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgG
RP-343 10 ug
EUR 343.2

Control siRNA Vector (pGB-control)
9500C-20 each
EUR 405.6

OOSA10387-100T - IgM NEGATIVE CONTROL Negative/Isotype Control
OOSA10387-100T 100Tests
EUR 309

CypExpress Control
MBS480553-10g 10g
EUR 1905

CypExpress Control
MBS480553-1g 1g
EUR 320

CypExpress Control
MBS480553-5x10g 5x10g
EUR 8355

CypExpress Control
MBS480553-5x1g 5x1g
EUR 1220

Heparanase 1 Human Recombinant W.B Control (HPA1 W.B. Control)
PT_73740
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ng
  • 200 ng
  • 300 ng

OOSA10342-100UG - IgG1 NEGATIVE CONTROL Negative/Isotype Control
OOSA10342-100UG 0.1mg
EUR 219

OOSA10349-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control
OOSA10349-100T 100Tests
EUR 299

OOSA10380-100T - IgG2b NEGATIVE CONTROL Negative/Isotype Control
OOSA10380-100T 100Tests
EUR 309

OOSA10389-100T - IgG1 NEGATIVE CONTROL Negative/Isotype Control
OOSA10389-100T 100Tests
EUR 309

OOSA10397-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control
OOSA10397-100T 100Tests
EUR 309

ODN 2088 control
tlrl-2088c-1 1 mg
EUR 546

ODN 2395 control
tlrl-2395c-1 1 mg
EUR 546

Anti-ROR1 (clone R11) scFv-Fc-Sec ADC
ADC-W-434 1mg Ask for price
Description: This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug

SARS-CoV-2 Nucleocapsid Protein scFv Antibody
abx229488-100g 100 µg
EUR 1725

Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control
MAMA-G081 1.5mm
EUR 50

Control FD TDM
K068M-6 6 x 5 mL
EUR 205
Description: Tri-Level

Control FD BNP
K023M-6 6 x 1 mL
EUR 292
Description: Bi-Level

SERION ELISA Avidity control Rubella Virus Avidity Control IgG
MBS191655-INQUIRE INQUIRE Ask for price

EDG-1 Control
BC-009 100 uL
EUR 350

EDG-2 Control
BC-011 100 uL
EUR 350

EDG-4 Control
BC-012 100 uL
EUR 350

EDG-6 Control
BC-014 100 uL
EUR 350

EDG-7 Control
BC-016 100 uL
EUR 350

Rat Control IgG
AC034 100 ul
EUR 24.09

Rat Control IgG
E45R13192N 50 ul
EUR 57.25

β-Gal Control
LV007 4 x 500 ul
EUR 195

Rat Control IgG
MBS9144358-01mL 0.1mL
EUR 140

Rat Control IgG
MBS9144358-5x01mL 5x0.1mL
EUR 465

NF-κB Control
T37559-10mg 10mg Ask for price
Description: NF-κB Control

NF-κB Control
T37559-1g 1g Ask for price
Description: NF-κB Control

NF-κB Control
T37559-1mg 1mg Ask for price
Description: NF-κB Control

NF-κB Control
T37559-50mg 50mg Ask for price
Description: NF-κB Control

NF-κB Control
T37559-5mg 5mg Ask for price
Description: NF-κB Control

Anti-COVID-19 Nucleocapsid Protein scFv Antibody
E38A9964 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-COVID-19 Nucleocapsid Protein scFv Antibody
MBS8309653-01mL 0.1mL
EUR 285

Anti-COVID-19 Nucleocapsid Protein scFv Antibody
MBS8309653-1mL 1mL
EUR 1585

Anti-COVID-19 Nucleocapsid Protein scFv Antibody
MBS8309653-5x1mL 5x1mL
EUR 7045

Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control
GCDFP081 1.5mm
EUR 50

Goat IgG Control
GT15900 1 mg
EUR 199.2

Rat IgG1 Control
mabg1-ctlrt 100 µg Ask for price

Goat IgG control
MBS536227-1mg 1mg
EUR 255

Goat IgG control
MBS536227-5x1mg 5x1mg
EUR 1000

2'3'-cGAMP Control
tlrl-nagpap 1 mg
EUR 235.2

G3-YSD Control
tlrl-ydnac 200 µg
EUR 148.05

MG-BSA Control
STA-306 100 µg
EUR 386.4
Description:
  • Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL

SERION ELISA Avidity control Toxoplasma gondii Avidity Control IgG
MBS191654-INQUIRE INQUIRE Ask for price

Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control
MSH2081 1.5mm
EUR 50

Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control
OLIG2081 1.5mm
EUR 50

OOSA10361-1ML - Rat IgG2a NEGATIVE CONTROL Negative/Isotype Control
OOSA10361-1ML 1ml
EUR 169

Mouse Control IgG
AC040 100μL
EUR 56.68

Mouse Control IgG
AC011 100 ul
EUR 24.09
Description: None

Mouse IgM Control
ICIGMF-100 100 µg
EUR 239.4

Mouse IgM Control
ICIGMPU-100 100 µg
EUR 239.4

human IgM control
E4A11C04 50ug
EUR 255
Description: Available in various conjugation types.

human IgE control
E4A11C05 50ug
EUR 255
Description: Available in various conjugation types.

human IgM control
E4A11D04 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human IgE control
E4A11D05 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human IgA control
E4A11D27 100ug
EUR 595

human IgG control
E4A11D28 100ug
EUR 295

Mouse Control IgG
E45M22043N 50 ul
EUR 57.25

Mouse Control IgG
E45M22049N 500 ul
EUR 603.25

Rat IgG2a Control
mabg2a-ctlrt 100 µg
EUR 101.85

Rat IgG2a Control
mabg2a-ctlrt-05 5 x 100 µg
EUR 163.8

Rat IgG2b Control
mabg2b-ctlrt 100 µg Ask for price

Due to the lack of vascular distribution and the sluggish metabolism, cartilage tissue can’t restore itself, which stays an enormous problem for cartilage regeneration. Tissue engineering utilizing stem cells seems to be a promising technique for cartilage restore. Tissue engineers demonstrated that mechanical stimulation can improve the high quality of engineered cartilage, making it extra much like pure cartilage in construction and performance. In this evaluate, we summarize current research on the position of mechanical stimuli in chondrogenesis, specializing in the purposes of extrinsic mechanical loading and the research on mechanical properties of biomaterials in cartilage tissue engineering. This evaluate will present contemporary insights into the potential use of mechanical stimuli for scientific use.

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Violet Rodriguez

Hydrogels are hydrophilic 3D networks which might be capable of ingest massive quantities of water or organic fluids, and are potential candidates for biosensors, drug supply vectors, vitality harvester gadgets, and carriers or matrices for cells in tissue engineering. Natural polymers, e.g., cellulose, chitosan and starch, have glorious properties that afford fabrication of superior hydrogel supplies for biomedical functions: biodegradability, biocompatibility, non-toxicity, hydrophilicity, thermal and chemical stability, and the excessive capability for swelling induced by facile artificial modification, amongst different physicochemical properties.

Hydrogels require variable time to succeed in an equilibrium swelling as a result of the variable diffusion charges of water sorption, capillary motion, and different modalities. In this examine, the nature, transport kinetics, and the function of water in the formation and structural stability of numerous varieties of hydrogels comprised of pure polymers are reviewed.Since water is an integral half of hydrogels that represent a substantive portion of its composition, there’s a must receive an improved understanding of the function of hydration in the construction, diploma of swelling and the mechanical stability of such biomaterial hydrogels.

The capability of the polymer chains to swell in an aqueous solvent will be expressed by the rubber elasticity concept and different thermodynamic contributions; whereas the charge of water diffusion will be pushed both by focus gradient or chemical potential. An overview of fabrication methods for numerous varieties of hydrogels is offered in addition to their responsiveness to exterior stimuli, together with their potential utility in numerous and novel functions. This overview goals to shed gentle on the function of hydration to the construction and perform of hydrogels. In flip, this overview will additional contribute to the improvement of superior supplies, reminiscent of “injectable hydrogels” and super-adsorbents for functions in the subject of environmental science and biomedicine.

Formation of contractile 3D bovine muscle tissue for development of millimetre-thick cultured steak

Owing to the enhance in the international demand of meat, cultured meat expertise is being developed to bypass a scarcity of meat in the future. However, strategies for development of millimetre-thick bovine muscle tissues with extremely aligned myotubes haven’t but been established. Here, we suggest a tradition technique for establishing 3D-cultured bovine muscle tissue containing myotubes aligned alongside its long-axial course, which contracted in response to electrical stimulation.

First, we optimised the composition of biomaterials utilized in the development and the electrical stimulation utilized to the tissue throughout tradition. Subsequently, we fabricated millimetre-thick bovine muscle tissues containing extremely aligned myotubes by accumulating bovine myoblast-laden hydrogel modules. The microbial content material of the bovine muscle tissue cultured for 14 days was beneath the detection restrict, indicating that the muscle tissues have been sterile, not like business meat. Therefore, the proposed development technique for bovine muscle tissues can be helpful for the manufacturing of clear cultured steak meat simulating actual meat.

The synergistic union of nanomaterials with biomaterials has revolutionized artificial chemistry, enabling the creation of nanomaterial-based biohybrids with distinct properties for biomedical functions. This class of supplies has drawn vital scientific curiosity from the perspective of purposeful extension by way of controllable coupling of artificial and biomaterial parts, leading to enhancement of the chemical, bodily, and organic properties of the obtained biohybrids.

In this overview, we spotlight the forefront supplies for the mixture with biomacromolecules and residing organisms and their advantageous properties in addition to latest advances in the rational design and synthesis of synthetic biohybrids. We additional illustrate the unbelievable variety of biomedical functions stemming from artificially bioaugmented traits of the nanomaterial-based biohybrids. Eventually, we intention to encourage scientists with the software horizons of the thrilling subject of artificial augmented biohybrids.

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Current Insights Into 3D Bioprinting: An Advanced Approach for Eye Tissue Regeneration

Three-dimensional (3D) printing is a recreation changer expertise that holds nice promise for all kinds of biomedical functions, together with ophthalmology. Through this rising method, particular eye tissues will be custom-fabricated in a versatile and automated method, incorporating completely different cell varieties and biomaterials in exact anatomical 3D geometries. However, and regardless of the nice progress and prospects generated lately, there are nonetheless challenges to beat that jeopardize its scientific software in common apply. The predominant aim of this overview is to offer an in-depth understanding of the present standing and implementation of 3D bioprinting expertise in the ophthalmology subject in an effort to manufacture related tissues reminiscent of cornea, retina and conjunctiva.

Goat IgG Isotype Control
GWB-B5EB81 100 TESTS Ask for price

Goat IgG Isotype Control
GWB-D15A0C 100 TESTS Ask for price

Goat IgG Isotype Control
GWB-7B95C3 0.5 mg Ask for price

Goat IgG Isotype Control
GWB-1D14C3 100 TESTS Ask for price

Goat IgG Isotype Control
GWB-224618 10 mg Ask for price

Goat IgG isotype control
MBS176681-1mg 1mg
EUR 115

Goat IgG isotype control
MBS176681-5mg 5mg
EUR 150

Goat IgG isotype control
MBS176681-5x5mg 5x5mg
EUR 525

IgG, Goat Isotype Control
MBS655594-5mg 5mg
EUR 370

IgG, Goat Isotype Control
MBS655594-5x5mg 5x5mg
EUR 1505

IgG, Goat Isotype Control
MBS655640-4mg 4mg
EUR 385

IgG, Goat Isotype Control
MBS655640-5x4mg 5x4mg
EUR 1590

PE Goat IgG Isotype Control
E16FGCP006-100 100 tests
EUR 368.33
Description: Available in various conjugation types.

Goat IgG (isotype control), PE
MBS524509-01mg 0.1mg
EUR 225

Goat IgG (isotype control), FITC
MBS524507-01mg 0.1mg
EUR 230

Goat IgG Isotype Control Antibody
MBS1564669-01mg 0.1mg
EUR 340

Goat IgG Isotype Control Antibody
MBS1564669-5x01mg 5x0.1mg
EUR 1235

Goat IgG (isotype control), Purified
MBS524504-2mg 2mg
EUR 230

IgG, Fc, Goat Isotype Control
MBS655649-2mg 2mg
EUR 425

IgG, Fc, Goat Isotype Control
MBS655649-5x2mg 5x2mg
EUR 1770

IgG, Goat Isotype Control (APC)
MBS655539-100Tests 100Tests
EUR 385

IgG, Goat Isotype Control (APC)
MBS655539-5x100Tests 5x100Tests
EUR 1580

IgG, Fab, Goat Isotype Control
MBS655666-5mg 5mg
EUR 400

IgG, Fab, Goat Isotype Control
MBS655666-5x5mg 5x5mg
EUR 1650

IgG, Goat Isotype Control (FITC)
MBS655763-100Tests 100Tests
EUR 320

IgG, Goat Isotype Control (FITC)
MBS655763-5x100Tests 5x100Tests
EUR 1285

IgG, Goat Isotype Control (Biotin)
MBS655622-05mg 0.5mg
EUR 345

IgG, Goat Isotype Control (Biotin)
MBS655622-5x05mg 5x0.5mg
EUR 1410

Goat F(ab')2 IgG Isotype Control
abx405076-05mg 0.5 mg
EUR 493.2

Goat F(ab')2 IgG Isotype Control
abx405076-250g 250 µg
EUR 300

Goat F(ab )2 IgG Isotype Control
GWB-953EBC 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-A21E37 0.5 mg Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-ECE6CB 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-B1F87E 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-CF433F 5 mg Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-4FA356 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-712793 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control
GWB-827F32 100 TESTS Ask for price

IgG, Goat Isotype Control (PE/Cy7)
MBS655499-100Tests 100Tests
EUR 385

IgG, Goat Isotype Control (PE/Cy7)
MBS655499-5x100Tests 5x100Tests
EUR 1580

IgG, Goat Isotype Control (PE/CY5)
MBS655517-100Tests 100Tests
EUR 380

IgG, Goat Isotype Control (PE/CY5)
MBS655517-5x100Tests 5x100Tests
EUR 1560

Goat IgG-PE conjugate (isotype control)
20011-PE 100 tests
EUR 270

Goat IgG-HRP conjugate (isotype control)
20011-HP 100 ug
EUR 196.8

Goat IgG-FITC conjugate (isotype control)
20011-F 100 ug
EUR 196.8

Goat F(ab')2 IgG Isotype Control (PE)
abx405078-100g 100 µg
EUR 437.5

Goat F(ab')2 IgG Isotype Control (RPE)
abx405078-05ml 0.5 ml
EUR 644.4

Goat F(ab')2 IgG Isotype Control (FITC)
abx405077-100g 100 µg
EUR 387.5

Goat F(ab')2 IgG Isotype Control (FITC)
abx405077-100tests 100 tests
EUR 594

Goat IgG (-ve control for flow cytometry) (isotype control)
20011-100 100 test
EUR 123.6

Alexa Fluor® 647 Goat IgG Isotype Control
E16FGCK006-100 100 tests
EUR 563.33
Description: Available in various conjugation types.

Normal Goat Polyclonal Isotype Control IgG
nAP-0014 1mg
EUR 459

Goat IgG (fc)-HRP conjugate (isotype control)
20011-Fc-HP 100 ug
EUR 196.8

Goat IgG (fc)-FITC conjugate (isotype control)
20011-Fc-F 100 ug
EUR 196.8

Goat IgG (fc)-Biotin conjugate (isotype control)
20011-Fc-B 100 ug
EUR 196.8

Goat IgG, purified (serum non-immune, isotype control)
20011-25 25 mg
EUR 562.8

Goat IgG, purified (serum non-immune, isotype control)
20011-5 5 mg
EUR 343.2

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 242.4

Rat IgG-HRP conjugate (isotype control) (Isotype control)
20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)
20005-F 100 ug
EUR 196.8

Rat IgG-Biotin conjugate (isotype control) (Isotype control)
20005-B 100 ug
EUR 196.8

OOSA10406-500UG - GOAT F(ab')2 IgG NEGATIVE CONTROL Negative/Isotype Control
OOSA10406-500UG 0.5mg
EUR 339

Rat IgG Isotype Control
GWB-D9CFB7 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-B6F703 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-F39C54 0.5 mg Ask for price

Rat IgG Isotype Control
GWB-F7A192 0.5 mg Ask for price

Rat IgG Isotype Control
GWB-BEE47C 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-CFDA81 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-4BFFB2 0.5 mg Ask for price

Dog IgG Isotype Control
GWB-323C1E 5 mg Ask for price

Rat IgG Isotype Control
GWB-37FCE4 10 mg Ask for price

Rat IgG Isotype Control
GWB-76BDF3 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-787682 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-7A6404 0.1 mg Ask for price

Rat IgG Isotype Control
GWB-1E8B74 0.1 mg Ask for price

Rat IgG Isotype Control
MBS537341-10mg 10mg
EUR 380

Rat IgG Isotype Control
MBS537341-5x10mg 5x10mg
EUR 1550

Human IgG Isotype Control
DAGIC1333 10 mg
EUR 724.5
Description: Human

Mouse IgG Isotype Control
abx127121-100l 100 µl
EUR 150

Mouse IgG Isotype Control
abx127121-1ml 1 ml Ask for price

Mouse IgG Isotype Control
abx127121-200l 200 µl Ask for price

Mouse IgG Isotype Control
IC002-100ul 100ul
EUR 146.4

Mouse IgG Isotype Control
GWB-949104 0.1 mg Ask for price

Sheep IgG Isotype Control
GWB-9688FE 0.1 mg Ask for price

Mouse IgG Isotype Control
GWB-E00547 1 ml Ask for price

Mouse IgG Isotype Control
GWB-EDB4A9 0.5 mg Ask for price

Human IgG Isotype Control
GWB-BDF954 1 ml Ask for price

Mouse IgG Isotype Control
GWB-BEF412 0.1 mg Ask for price

Mouse IgG Isotype Control
GWB-D166E3 0.1 mg Ask for price

Mouse IgG Isotype Control
GWB-46ECA9 0.5 mg Ask for price

Mouse IgG Isotype Control
GWB-552B59 0.1 mg Ask for price

Human IgG Isotype Control
GWB-2CF422 1.0 mg Ask for price

Mouse IgG Isotype Control
GWB-2F1CBA 0.1 mg Ask for price

Human IgG Isotype Control
GWB-38F945 1 ml Ask for price

Sheep IgG Isotype Control
GWB-710114 5 mg Ask for price

Mouse IgG Isotype Control
GWB-75892E 0.1 mg Ask for price

Mouse IgG Isotype Control
GWB-1B0AB3 0.5 mg Ask for price

Mouse IgG Isotype Control
GWB-1BE5E5 10 mg Ask for price

Sheep IgG Isotype Control
GWB-1E6DA3 1 mg Ask for price

Mouse IgG Isotype Control
GWB-4662CD 0.1 mg Ask for price

Mouse IgG Isotype Control
MBS9436856-INQUIRE INQUIRE Ask for price

Rabbit IgG Isotype Control
abx125003-100l 100 µl
EUR 150

Rabbit IgG Isotype Control
abx125003-100ul 100 ul
EUR 243.6

Rabbit IgG Isotype Control
abx125003-1ml 1 ml Ask for price

Rabbit IgG Isotype Control
abx125003-200l 200 µl Ask for price

Rabbit IgG Isotype Control
BS47451 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Rabbit IgG isotype control
AC042 100μL
EUR 70.85
Description: None

Rabbit IgG isotype control
AC045 200μL
EUR 56.68

Rabbit IgG isotype control
AC046 200μL
EUR 92.11

Rabbit IgG Isotype Control
CABT-B8382 500 µg
EUR 598.5
Description: Rabbit

Rabbit IgG Isotype Control
IC001-100ul 100ul
EUR 146.4

Rabbit IgG Isotype Control
GWB-F3BC41 10 mg Ask for price

Special consideration is paid to the description of the mostly employed bioprinting strategies, and the most related eye tissue engineering research carried out by 3D bioprinting expertise at preclinical stage. In addition, different related points associated to make use of of 3D bioprinting for ocular drug supply, in addition to each moral and regulatory points, are analyzed. Through this overview, we intention to lift consciousness amongst the analysis neighborhood and report latest advances and future instructions in an effort to apply this superior remedy in the eye tissue regeneration subject.

Machine learning active-nematic hydrodynamics

Machine learning active-nematic hydrodynamics

Violet Rodriguez

Hydrodynamic theories successfully describe many-body programs out of equilibrium when it comes to just a few macroscopic parameters. However, such parameters are troublesome to find out from microscopic data. Seldom is that this problem extra obvious than in lively matter, the place the hydrodynamic parameters are actually fields that encode the distribution of energy-injecting microscopic parts. Here, we use lively nematics to reveal that neural networks can map out the spatiotemporal variation of a number of hydrodynamic parameters and forecast the chaotic dynamics of those programs.

We analyze biofilament/molecular-motor experiments with microtubule/kinesin and actin/myosin complexes as laptop imaginative and prescient issues. Our algorithms can decide how exercise and elastic moduli change as a operate of area and time, in addition to adenosine triphosphate (ATP) or motor focus. The solely enter wanted is the orientation of the biofilaments and never the coupled velocity subject which is tougher to entry in experiments. We may also forecast the evolution of those chaotic many-body programs solely from picture sequences of their previous utilizing a mixture of autoencoders and recurrent neural networks with residual structure. In life like experimental setups for which the preliminary circumstances will not be completely identified, our physics-inspired machine-learning algorithms can surpass deterministic simulations.

Blending of various biopolymers, e.g., collagen, chitosan, silk fibroin and cross-linking modifications of those mixtures can result in new supplies with improved physico-chemical properties, in comparison with single-component scaffolds. Three-dimensional scaffolds based mostly on three-component mixtures of silk fibroin, collagen and chitosan, chemically cross-linked, have been ready and their physico-chemical and organic properties have been evaluated. A mix of EDC (N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride) and NHS (N-hydroxysuccinimide) was used as a cross-linking agent. FTIR was used to watch the place of the peaks attribute for collagen, chitosan and silk fibroin. The following properties relying on the scaffold construction have been studied: swelling conduct, liquid uptake, moisture content material, porosity, density, and mechanical parameters.

Scanning Electron Microscopy imaging was carried out. Additionally, the organic properties of those supplies have been assessed, by metabolic exercise assay. The outcomes confirmed that the three-component mixtures, cross-linked by EDC/NHS and ready by lyophilization methodology, offered porous constructions. They have been characterised by a excessive swelling diploma. The composition of scaffolds has an affect on mechanical properties. All of the studied supplies have been cytocompatible with MG-63 osteoblast-like cells. Our research paves the way in which for artificial-intelligence characterization and management of coupled chaotic fields in numerous bodily and organic programs, even within the absence of information of the underlying dynamics.

Machine learning active-nematic hydrodynamics

Evaluating Whole Blood Clotting in vitro on Biomaterial Surfaces

Biomaterial-associated thrombosis continues to be a significant concern for blood-contacting implants. After the medical system is implanted and is available in contact with blood, a number of advanced reactions happen, which can result in thrombus formation and failure of the system. Therefore, it’s important to guage the biomaterial interplay with the entire blood. Several research have been reported within the literature that consider completely different steps within the coagulation cascade, resembling protein adsorption, plasma activation, and platelet adhesion in vitro, nonetheless, analysis of complete blood clotting on biomaterial surfaces is just not extensively reported.

Here, a protocol to guage complete blood clotting in vitro on 2D biomaterials surfaces by way of a easy and quick hemolysis assay is offered. Whole human blood is positioned onto the biomaterial surfaces and is allowed to clot for various time durations. After the particular time intervals, the surfaces are transferred into deionized (DI) water to launch the free hemoglobin and the absorbance of this answer is measured. The absorbance worth is proportional to the free hemoglobin focus within the DI water as a consequence of lysis of crimson blood cells and offers an oblique correlation to the extent of blood clotting on the biomaterial surfaces. This protocol offers a quick, facile and efficient methodology to measure the anti-thrombogenic properties of biomaterials.

Hamster IgG Isotype Control
GWB-528DB9 0.1 mg Ask for price

Hamster IgG Isotype Control
GWB-6571A8 0.5 mg Ask for price

Hamster IgG Isotype Control
GWB-30C10C 0.1 mg Ask for price

Hamster IgG Isotype Control
GWB-3114BE 0.5 mg Ask for price

Hamster IgG Isotype Control
GWB-3413D0 0.1 mg Ask for price

Hamster IgG Isotype Control
GWB-1A8D7A 0.1 mg Ask for price

Hamster IgG Isotype Control
GWB-419E75 0.1 mg Ask for price

IgG, Hamster Isotype Control
MBS655561-05mg 0.5mg
EUR 425

IgG, Hamster Isotype Control
MBS655561-5x05mg 5x0.5mg
EUR 1765

Syrian Hamster IgG Isotype Control
SIGGA-100 100 µg
EUR 688.99

Syrian Hamster IgG Isotype Control
SIGGB-200 200 µg
EUR 566.69

Syrian Hamster IgG Isotype Control
SIGGF-200 200 µg
EUR 654.05

Syrian Hamster IgG Isotype Control
SIGGPE-100 100 µg
EUR 619.1

Syrian Hamster IgG Isotype Control
SIGGPP5.5-100 100 µg
EUR 811.3

Syrian Hamster IgG Isotype Control
SIGGPP5.5-25 25 µg
EUR 426.91

Syrian Hamster IgG Isotype Control
SIGGPU-500 500 µg
EUR 514.27

Armenian Hamster IgG Isotype Control
ab-131-433 500 µg
EUR 290

Armenian Hamster IgG Isotype control
AIGGA-100 100 µg
EUR 688.99

Armenian Hamster IgG Isotype control
AIGGA-25 25 µg
EUR 339.55

Armenian Hamster IgG Isotype control
AIGGB-200 200 µg
EUR 566.69

Armenian Hamster IgG Isotype control
AIGGB-50 50 µg
EUR 287.14

Armenian Hamster IgG Isotype control
AIGGF-200 200 µg
EUR 654.05

Armenian Hamster IgG Isotype control
AIGGF-50 50 µg
EUR 322.08

Armenian Hamster IgG Isotype control
AIGGPE-100 100 µg
EUR 619.1

Armenian Hamster IgG Isotype control
AIGGPE-25 25 µg
EUR 304.61

Armenian Hamster IgG Isotype control
AIGGPP-100 100 µg
EUR 688.99

Armenian Hamster IgG Isotype control
AIGGPP-25 25 µg
EUR 322.08

Armenian Hamster IgG Isotype control
AIGGPP5.5-100 100 µg
EUR 776.35

Armenian Hamster IgG Isotype control
AIGGPP5.5-25 25 µg
EUR 339.55

Armenian Hamster IgG Isotype control
AIGGPU-50 50 µg
EUR 234.72

Armenian Hamster IgG Isotype control
AIGGPU-500 500 µg
EUR 514.27

Armenian Hamster IgG Isotype Control
MBS378382-05mg 0.5mg
EUR 410

Armenian Hamster IgG Isotype Control
MBS378382-5x05mg 5x0.5mg
EUR 1550

IgG, Hamster Isotype Control (PE)
MBS655567-01mg 0.1mg
EUR 460

IgG, Hamster Isotype Control (PE)
MBS655567-5x01mg 5x0.1mg
EUR 1920

Hamster (Syrian) IgG Isotype Control
abx405032-025mg 0.25 mg
EUR 460.8

IgG, Hamster Isotype Control (Cy5)
MBS655525-01mg 0.1mg
EUR 490

IgG, Hamster Isotype Control (Cy5)
MBS655525-5x01mg 5x0.1mg
EUR 2050

IgG, Hamster Isotype Control (APC)
MBS655650-01mg 0.1mg
EUR 480

IgG, Hamster Isotype Control (APC)
MBS655650-5x01mg 5x0.1mg
EUR 2005

IgG, Hamster Isotype Control (FITC)
MBS655614-05mg 0.5mg
EUR 545

IgG, Hamster Isotype Control (FITC)
MBS655614-5x05mg 5x0.5mg
EUR 2310

Hamster (Armenian) IgG Isotype Control
abx405028-025mg 0.25 mg
EUR 460.8

Hamster (Arnenian) IgG Isotype Control
abx405029-05mg 0.5 mg
EUR 710.4

PE Syrian Hamster IgG Isotype Control
DL22376F-20Tests 20Tests
EUR 158

PE Syrian Hamster IgG Isotype Control
DL22376F-50Tests 50Tests
EUR 233

PE Syrian Hamster IgG Isotype Control
DL22391F-25ug 25μg
EUR 137

PE Syrian Hamster IgG Isotype Control
DL22391F-50ug 50μg
EUR 182

PE Syrian Hamster IgG Isotype Control
JOT22376F 20Tests
EUR 143.78
Description: PE

PE Syrian Hamster IgG Isotype Control
JOT22391F 25μg
EUR 124.67
Description: PE

PE Syrian Hamster IgG Isotype Control
RD22376F-100Tests 100Tests
EUR 123

PE Syrian Hamster IgG Isotype Control
RD22376F-100Testsx2 100Testsx2
EUR 168

PE Syrian Hamster IgG Isotype Control
RD22376F-20Tests 20Tests
EUR 48

PE Syrian Hamster IgG Isotype Control
RD22391F-100ug 100μg
EUR 75

PE Syrian Hamster IgG Isotype Control
RD22391F-25ug 25μg
EUR 31.5

IgG, Hamster Isotype Control (Biotin)
MBS655743-05mg 0.5mg
EUR 545

IgG, Hamster Isotype Control (Biotin)
MBS655743-5x05mg 5x0.5mg
EUR 2310

FITC Syrian Hamster IgG Isotype Control
DL22375F-20Tests 20Tests
EUR 158

FITC Syrian Hamster IgG Isotype Control
DL22375F-50Tests 50Tests
EUR 233

FITC Syrian Hamster IgG Isotype Control
DL22390F-25ug 25μg
EUR 137

FITC Syrian Hamster IgG Isotype Control
DL22390F-50ug 50μg
EUR 182

PE Armenian Hamster IgG Isotype Control
DL22565F-20Tests 20Tests
EUR 158

PE Armenian Hamster IgG Isotype Control
DL22565F-50Tests 50Tests
EUR 233

PE Armenian Hamster IgG Isotype Control
DL22580F-25ug 25μg
EUR 137

PE Armenian Hamster IgG Isotype Control
DL22580F-50ug 50μg
EUR 182

FITC Syrian Hamster IgG Isotype Control
JOT22375F 20Tests
EUR 143.78
Description: FITC

FITC Syrian Hamster IgG Isotype Control
JOT22390F 25μg
EUR 124.67
Description: FITC

PE Armenian Hamster IgG Isotype Control
JOT22565F 20Tests
EUR 143.78
Description: PE

PE Armenian Hamster IgG Isotype Control
JOT22580F 25μg
EUR 124.67
Description: PE

PE Armenian Hamster IgG Isotype Control
E16FTCP006-025U 25 μg
EUR 303.33
Description: Available in various conjugation types.

PE Armenian Hamster IgG Isotype Control
E16FTCP006-100U 100 μg
EUR 693.33
Description: Available in various conjugation types.

Armenian Hamster IgG Isotype Control PE
MBS697168-005mg 0.05mg
EUR 195

Armenian Hamster IgG Isotype Control PE
MBS697168-02mg 0.2mg
EUR 390

Armenian Hamster IgG Isotype Control PE
MBS697168-5x02mg 5x0.2mg
EUR 1715

FITC Syrian Hamster IgG Isotype Control
RD22375F-100Tests 100Tests
EUR 123

FITC Syrian Hamster IgG Isotype Control
RD22375F-100Testsx2 100Testsx2
EUR 168

FITC Syrian Hamster IgG Isotype Control
RD22375F-20Tests 20Tests
EUR 48

FITC Syrian Hamster IgG Isotype Control
RD22390F-100ug 100μg
EUR 75

FITC Syrian Hamster IgG Isotype Control
RD22390F-25ug 25μg
EUR 31.5

PE Armenian Hamster IgG Isotype Control
RD22565F-100Tests 100Tests
EUR 123

PE Armenian Hamster IgG Isotype Control
RD22565F-100Testsx2 100Testsx2
EUR 168

PE Armenian Hamster IgG Isotype Control
RD22565F-20Tests 20Tests
EUR 48

PE Armenian Hamster IgG Isotype Control
RD22580F-100ug 100μg
EUR 75

PE Armenian Hamster IgG Isotype Control
RD22580F-25ug 25μg
EUR 31.5

AF488 Syrian Hamster IgG Isotype Control
DL22384F-20Tests 20Tests
EUR 185

AF488 Syrian Hamster IgG Isotype Control
DL22384F-50Tests 50Tests
EUR 267.5

AF647 Syrian Hamster IgG Isotype Control
DL22385F-20Tests 20Tests
EUR 185

AF647 Syrian Hamster IgG Isotype Control
DL22385F-50Tests 50Tests
EUR 267.5

AF488 Syrian Hamster IgG Isotype Control
DL22399F-25ug 25μg
EUR 182

AF488 Syrian Hamster IgG Isotype Control
DL22399F-50ug 50μg
EUR 272

AF647 Syrian Hamster IgG Isotype Control
DL22400F-25ug 25μg
EUR 182

AF647 Syrian Hamster IgG Isotype Control
DL22400F-50ug 50μg
EUR 272

APC Armenian Hamster IgG Isotype Control
DL22566F-20Tests 20Tests
EUR 170

APC Armenian Hamster IgG Isotype Control
DL22566F-50Tests 50Tests
EUR 245

APC Armenian Hamster IgG Isotype Control
DL22581F-25ug 25μg
EUR 147.5

APC Armenian Hamster IgG Isotype Control
DL22581F-50ug 50μg
EUR 197

AF488 Syrian Hamster IgG Isotype Control
JOT22384F 20Tests
EUR 168.35
Description: AF488

AF647 Syrian Hamster IgG Isotype Control
JOT22385F 20Tests
EUR 168.35
Description: AF647

AF488 Syrian Hamster IgG Isotype Control
JOT22399F 25μg
EUR 165.62
Description: AF488

AF647 Syrian Hamster IgG Isotype Control
JOT22400F 25μg
EUR 165.62
Description: AF647

APC Armenian Hamster IgG Isotype Control
JOT22566F 20Tests
EUR 154.7
Description: APC

APC Armenian Hamster IgG Isotype Control
JOT22581F 25μg
EUR 134.23
Description: APC

EV450 Syrian Hamster IgG Isotype Control
JOT22756F 20Tests
EUR 247.52
Description: EV450

EV450 Syrian Hamster IgG Isotype Control
JOT22757F 25μg
EUR 247.52
Description: EV450

APC Armenian Hamster IgG Isotype Control
E16FTCA006-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

APC Armenian Hamster IgG Isotype Control
E16FTCA006-100U 100 μg
EUR 780
Description: Available in various conjugation types.

Armenian Hamster IgG Isotype Control APC
MBS697169-01mg 0.1mg
EUR 325

Armenian Hamster IgG Isotype Control APC
MBS697169-5x01mg 5x0.1mg
EUR 1410

AF488 Syrian Hamster IgG Isotype Control
RD22384F-100Tests 100Tests
EUR 225

AF488 Syrian Hamster IgG Isotype Control
RD22384F-100Testsx2 100Testsx2
EUR 360

AF488 Syrian Hamster IgG Isotype Control
RD22384F-20Tests 20Tests
EUR 75

AF647 Syrian Hamster IgG Isotype Control
RD22385F-100Tests 100Tests
EUR 225

AF647 Syrian Hamster IgG Isotype Control
RD22385F-100Testsx2 100Testsx2
EUR 360

AF647 Syrian Hamster IgG Isotype Control
RD22385F-20Tests 20Tests
EUR 75

AF488 Syrian Hamster IgG Isotype Control
RD22399F-100ug 100μg
EUR 225

AF488 Syrian Hamster IgG Isotype Control
RD22399F-25ug 25μg
EUR 75

AF647 Syrian Hamster IgG Isotype Control
RD22400F-100ug 100μg
EUR 225

AF647 Syrian Hamster IgG Isotype Control
RD22400F-25ug 25μg
EUR 75

APC Armenian Hamster IgG Isotype Control
RD22566F-100Tests 100Tests
EUR 165

APC Armenian Hamster IgG Isotype Control
RD22566F-100Testsx2 100Testsx2
EUR 240

APC Armenian Hamster IgG Isotype Control
RD22566F-20Tests 20Tests
EUR 60

APC Armenian Hamster IgG Isotype Control
RD22581F-100ug 100μg
EUR 103.5

APC Armenian Hamster IgG Isotype Control
RD22581F-25ug 25μg
EUR 45

Biotin Syrian Hamster IgG Isotype Control
DL22389F-25ug 25μg
EUR 137

Biotin Syrian Hamster IgG Isotype Control
DL22389F-50ug 50μg
EUR 182

FITC Armenian Hamster IgG Isotype Control
DL22564F-20Tests 20Tests
EUR 158

FITC Armenian Hamster IgG Isotype Control
DL22564F-50Tests 50Tests
EUR 233

FITC Armenian Hamster IgG Isotype Control
DL22579F-25ug 25μg
EUR 137

FITC Armenian Hamster IgG Isotype Control
DL22579F-50ug 50μg
EUR 182

Biotin Syrian Hamster IgG Isotype Control
JOT22389F 25μg
EUR 124.67
Description: Biotin

FITC Armenian Hamster IgG Isotype Control
JOT22564F 20Tests
EUR 143.78
Description: FITC

FITC Armenian Hamster IgG Isotype Control
JOT22579F 25μg
EUR 124.67
Description: FITC

FITC Armenian Hamster IgG Isotype Control
E16FTCF006-200U 200 μg
EUR 736.67
Description: Available in various conjugation types.

Armenian Hamster IgG Isotype Control FITC
MBS697167-005mg 0.05mg
EUR 205

Armenian Hamster IgG Isotype Control FITC
MBS697167-02mg 0.2mg
EUR 405

Armenian Hamster IgG Isotype Control FITC
MBS697167-05mg 0.5mg
EUR 405

Armenian Hamster IgG Isotype Control FITC
MBS697167-5x02mg 5x0.2mg
EUR 1770

Biotin Syrian Hamster IgG Isotype Control
RD22389F-100ug 100μg
EUR 75

Biotin Syrian Hamster IgG Isotype Control
RD22389F-25ug 25μg
EUR 31.5

FITC Armenian Hamster IgG Isotype Control
RD22564F-100Tests 100Tests
EUR 123

FITC Armenian Hamster IgG Isotype Control
RD22564F-100Testsx2 100Testsx2
EUR 168

FITC Armenian Hamster IgG Isotype Control
RD22564F-20Tests 20Tests
EUR 48

FITC Armenian Hamster IgG Isotype Control
RD22579F-100ug 100μg
EUR 75

FITC Armenian Hamster IgG Isotype Control
RD22579F-25ug 25μg
EUR 31.5

AF647 Armenian Hamster IgG Isotype Control
DL22574F-20Tests 20Tests
EUR 185

AF647 Armenian Hamster IgG Isotype Control
DL22574F-50Tests 50Tests
EUR 267.5

AF488 Armenian Hamster IgG Isotype Control
DL22588F-25ug 25μg
EUR 182

AF488 Armenian Hamster IgG Isotype Control
DL22588F-50ug 50μg
EUR 272

AF647 Armenian Hamster IgG Isotype Control
DL22589F-25ug 25μg
EUR 182

AF647 Armenian Hamster IgG Isotype Control
DL22589F-50ug 50μg
EUR 272

AF647 Armenian Hamster IgG Isotype Control
JOT22574F 20Tests
EUR 168.35
Description: AF647

AF488 Armenian Hamster IgG Isotype Control
JOT22588F 25μg
EUR 165.62
Description: AF488

AF647 Armenian Hamster IgG Isotype Control
JOT22589F 25μg
EUR 165.62
Description: AF647

EV450 Armenian Hamster IgG Isotype Control
JOT22750F 20Tests
EUR 247.52
Description: EV450

EV450 Armenian Hamster IgG Isotype Control
JOT22751F 25μg
EUR 247.52
Description: EV450

ER780 Armenian Hamster IgG Isotype Control
JOT22812F 20Tests
EUR 247.52
Description: ER780

ER780 Armenian Hamster IgG Isotype Control
JOT22813F 25μg
EUR 247.52
Description: ER780

PerCP Armenian Hamster IgG Isotype Control
E16FTCR006-025U 25 μg
EUR 325
Description: Available in various conjugation types.

PerCP Armenian Hamster IgG Isotype Control
E16FTCR006-100U 100 μg
EUR 780
Description: Available in various conjugation types.

AF647 Armenian Hamster IgG Isotype Control
RD22574F-100Tests 100Tests
EUR 225

AF647 Armenian Hamster IgG Isotype Control
RD22574F-100Testsx2 100Testsx2
EUR 360

AF647 Armenian Hamster IgG Isotype Control
RD22574F-20Tests 20Tests
EUR 75

AF488 Armenian Hamster IgG Isotype Control
RD22588F-100ug 100μg
EUR 225

AF488 Armenian Hamster IgG Isotype Control
RD22588F-25ug 25μg
EUR 75

Spinal wire damage (SCI) usually ends in long-lasting useful deficits, largely as a consequence of major and secondary white matter injury on the website of damage. The transplantation of neural stem cells (NSCs) has proven promise for re-establishing communications between separated areas of the spinal wire by way of the insertion of latest neurons between the injured axons and goal neurons. However, the inhibitory microenvironment that develops after SCI usually causes endogenous and transplanted NSCs to distinguish into glial cells moderately than neurons. Functional biomaterials have been proven to mitigate the results of the antagonistic SCI microenvironment and promote the neuronal differentiation of NSCs.

A transparent understanding of the mechanisms of neuronal differentiation inside the injury-induced microenvironment would possible permit for the event of remedy methods designed to advertise the innate potential of NSCs to distinguish into neurons. The elevated differentiation of neurons might contribute to relay formation, facilitating useful restoration after SCI. In this assessment, we summarize present methods used to reinforce the neuronal differentiation of NSCs by way of the reconstruction of the SCI microenvironment and to enhance the intrinsic neuronal differentiation skills of NSCs, which is important for SCI restore.

Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

Violet Rodriguez

The use of decellularized extracellular matrix (dECM) as a biomaterial has been an vital step ahead for the event of purposeful tissue constructs. In addition to tissues and organs, cell cultures are gaining a lot of consideration as a substitute supply of dECM. In this work, a novel biomimetic hydrogel is developed primarily based on dECM obtained from mesenchymal stem cells (mdECM) for cartilage tissue engineering. To this finish, cells are seeded underneath particular tradition situations to generate an early chondrogenic extracellular matrix (ECM) offering cues and components essential for cartilage improvement.

The composition is decided by quantitative, histological, and mass spectrometry methods. Moreover, the decellularization course of is evaluated by measuring the DNA content material and compositional analyses, and the hydrogel is formulated at completely different concentrations (3% and 6% w/v). Results present that mdECM derived hydrogels possess glorious biocompatibility and appropriate physicochemical and mechanical properties for their injectability. Furthermore, it’s evidenced that this hydrogel is ready to induce chondrogenesis of mesenchymal stem cells (MSCs) with out supplemental components and, moreover, to kind hyaline cartilage-like tissue after in vivo implantation. These findings exhibit for the primary time the potential of this hydrogel primarily based on mdECM for functions in cartilage restore and regeneration.

Manufacturing macroscale cell-laden architectures is one of the most important challenges confronted these days within the area of tissue engineering. Such dwelling constructs, in reality, pose strict necessities for vitamins and oxygen provide that may hardly be addressed by means of easy diffusion in vitro or with out a purposeful vasculature in vivo. In this context, within the final twenty years, a substantial quantity of work has been carried out to develop sensible supplies that might actively present oxygen-release to distinction native hypoxia in large-size constructs.

This evaluation offers an summary of the at the moment obtainable oxygen-releasing supplies and their synthesis and mechanism of motion, highlighting their capacities underneath in vitro tissue cultures and in vivo contexts. Additionally, we additionally showcase an rising idea, herein termed as “dwelling supplies as releasing techniques”, which depends on the mixture of biomaterials with photosynthetic microorganisms, particularly algae, in an “unconventional” try to produce the broken or re-growing tissue with the required provide of oxygen.

Prionace glauca pores and skin collagen bioengineered constructs as a promising strategy to set off cartilage regeneration

Representing a technique of marine by-products valorization, primarily based on isolation of biocompounds and evaluation of biomedical applicability, the potential of blue shark (Prionace glauca (PG)) pores and skin collagen to induce chondrogenic differentiation of human adipose stem cells (hASC) was investigated, with and with out exogenous stimulation. For that, a cryogelation methodology was utilized to supply extremely interconnected porous three-d (3D) constructs made of collagen and collagen:hyaluronic acid (20:1). In vitro research reveal that hASC adhere abundantly to the constructs which then suggests the early chondrogenic differentiation of these cells.

These findings are supported by the mRNA expression encoding chondrogenic-related markers like Coll II and Sox-9 which can be markedly upregulated at an early stage for each situations, with and with out exogenous stimulation. The introduction of hyaluronic acid (Hya) appears to play a essential function at later time factors, as proven by the evident immunodetection of aggrecan (ACAN), even with out exogenous stimulation. It is hypothesized that the PG collagen itself can help chondrogenic differentiation at early time factors, however exogenous stimulation is required to make sure phenotype upkeep. The current work highlights the relevance of utilizing blue shark collagen biopolymer as a constructing block to supply extremely efficient short-term matrices for cartilage functions.

Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

L-histidine controls the hydroxyapatite mineralization with plate-like morphology: Effect of focus and media

Hydroxyapatite (HA) is the principle inorganic element of bone and dentin, and their non-stoichiometric compositions and plate-shaped morphology is accountable for their bioactivity and osteoconductive nature. Collagenous (CPs) and non-collagenous proteins (NCPs) facilitate mineralization and regulate structural properties of HA by means of their side-chains. The bioactivity of artificial HA doesn’t often match with the HA present in bone and, subsequently, there may be a want to know the function of biomolecules in bone mineralization with the intention to develop non-stoichiometric plate-shaped HA for bone grafts. Role of a number of amino acids has been investigated however the function of L-his has been not often investigated underneath physiological situations although it’s a half of HA inhibitor proteins, like albumin, amelogenin, and histidine-rich proteins.

Rat IgG2b Isotype Control
GWB-DCB94C 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-EBB1F5 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-F8EFA6 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-497BCA 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-66906E 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-6F4C48 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-7A14AF 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-259078 0.5 mg Ask for price

Rat IgG2b Isotype Control
GWB-1D8308 0.1 mg Ask for price

Rat IgG2b Isotype Control
GWB-10050E 0.5 mg Ask for price

Rat IgG2b Isotype Control
GWB-11EF45 0.5 mg Ask for price

Rat IgG2b Isotype Control
GWB-15EFE0 0.5 mg Ask for price

Rat IgG2b Isotype Control
GWB-1671C8 0.5 mg Ask for price

Rat IgG2b Isotype Control
MBS378374-05mg 0.5mg
EUR 410

Rat IgG2b Isotype Control
MBS378374-5x05mg 5x0.5mg
EUR 1550

Rat IgG2b Isotype Control
MBS539673-05mg 0.5mg
EUR 395

Rat IgG2b Isotype Control
MBS539673-5x05mg 5x0.5mg
EUR 1615

Rat IgG2b Isotype Control
RIGG2BA-100 100 µg
EUR 391.97

Rat IgG2b Isotype Control
RIGG2BA-25 25 µg
EUR 199.78

Rat IgG2b Isotype Control
RIGG2BB-200 200 µg
EUR 549.22

Rat IgG2b Isotype Control
RIGG2BB-50 50 µg
EUR 269.66

Rat IgG2b Isotype Control
RIGG2BF-200 200 µg
EUR 566.69

Rat IgG2b Isotype Control
RIGG2BF-50 50 µg
EUR 182.3

Rat IgG2b Isotype Control
RIGG2BPE-100 100 µg
EUR 322.08

Rat IgG2b Isotype Control
RIGG2BPE-25 25 µg
EUR 182.3

Rat IgG2b Isotype Control
RIGG2BPP-100 100 µg
EUR 688.99

Rat IgG2b Isotype Control
RIGG2BPP-25 25 µg
EUR 322.08

Rat IgG2b Isotype Control
RIGG2BPP5.5-100 100 µg
EUR 619.1

Rat IgG2b Isotype Control
RIGG2BPP5.5-25 25 µg
EUR 339.55

Rat IgG2b Isotype Control
RIGG2BPU-50 50 µg
EUR 147.36

Rat IgG2b Isotype Control
RIGG2BPU-500 500 µg
EUR 444.38

Rat IgG2b Isotype Control PE
1P-169-C100 0.1mg
EUR 198

Rat IgG2b Isotype Control (PE)
abx405055-200g 200 µg
EUR 250

Rat IgG2b Isotype Control (PE)
abx347145-100l 100 µl Ask for price

Rat IgG2b Isotype Control (PE)
abx347145-50l 50 µl
EUR 350

Rat IgG2b Isotype Control PE
MBS1801911-01mg 0.1mg
EUR 305

Rat IgG2b Isotype Control PE
MBS1801911-5x01mg 5x0.1mg
EUR 1120

Rat IgG2b Isotype Control PE
MBS697125-01mg 0.1mg
EUR 235

Rat IgG2b Isotype Control PE
MBS697125-5x01mg 5x0.1mg
EUR 1005

Rat IgG2b Isotype Control (APC)
abx405049-100g 100 µg
EUR 312.5

Rat IgG2b Isotype Control (APC)
abx405049-100tests 100 tests
EUR 510

Rat IgG2b Isotype Control (RPE)
abx405055-100tests 100 tests
EUR 427.2

Rat IgG2b Isotype Control APC
MBS697129-01mg 0.1mg
EUR 260

Rat IgG2b Isotype Control APC
MBS697129-5x01mg 5x0.1mg
EUR 1120

Rat IgG2b Isotype Control FITC
1F-169-C025 0.025 mg
EUR 82.5

Rat IgG2b Isotype Control FITC
1F-169-C100 0.1 mg
EUR 165

Rat IgG2b Isotype Control (FITC)
abx140596-100g 100 µg
EUR 300

Rat IgG2b Isotype Control (FITC)
abx405052-01mg 0.1 mg
EUR 410.4

Rat IgG2b Isotype Control (FITC)
abx405052-25g 25 µg
EUR 225

Rat IgG2b Isotype Control FITC
MBS1801521-01mg 0.1mg
EUR 280

Rat IgG2b Isotype Control FITC
MBS1801521-5x01mg 5x0.1mg
EUR 1020

Rat IgG2b Isotype Control FITC
MBS697124-01mg 0.1mg
EUR 215

Rat IgG2b Isotype Control FITC
MBS697124-5x01mg 5x0.1mg
EUR 925

Rat IgG2b Isotype Control (Biotin)
abx405050-01mg 0.1 mg
EUR 376.8

Rat IgG2b Isotype Control (Biotin)
abx405050-100g 100 µg
EUR 212.5

Rat IgG2b Isotype Control Purified
11-169-C100 0.1 mg
EUR 115.5

Rat IgG2b Isotype Control Purified
MBS1801519-01mg 0.1mg
EUR 235

Rat IgG2b Isotype Control Purified
MBS1801519-5x01mg 5x0.1mg
EUR 825

Rat IgG2b Isotype Control Purified
MBS697121-01mg 0.1mg
EUR 195

Rat IgG2b Isotype Control Purified
MBS697121-5x01mg 5x0.1mg
EUR 825

PE Rat IgG2b, κ Isotype Control
DL22538F-20Tests 20Tests
EUR 158

PE Rat IgG2b, κ Isotype Control
DL22538F-50Tests 50Tests
EUR 233

PE Rat IgG2b, κ Isotype Control
DL22553F-25ug 25μg
EUR 137

PE Rat IgG2b, κ Isotype Control
DL22553F-50ug 50μg
EUR 182

PE Rat IgG2b, κ Isotype Control
JOT22538F 20Tests
EUR 143.78
Description: PE

PE Rat IgG2b, κ Isotype Control
JOT22553F 25μg
EUR 124.67
Description: PE

PE rat IgG2b, κ Isotype Control
E16FRCP003K-025 25 tests
EUR 195
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control
E16FRCP003K-025U 25 μg
EUR 151.67
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control
E16FRCP003K-100 100 tests
EUR 346.67
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control
E16FRCP003K-100U 100 μg
EUR 325
Description: Available in various conjugation types.

PE Rat IgG2b, κ Isotype Control
RD22538F-100Tests 100Tests
EUR 123

PE Rat IgG2b, κ Isotype Control
RD22538F-100Testsx2 100Testsx2
EUR 168

PE Rat IgG2b, κ Isotype Control
RD22538F-20Tests 20Tests
EUR 48

PE Rat IgG2b, κ Isotype Control
RD22553F-100ug 100μg
EUR 75

PE Rat IgG2b, κ Isotype Control
RD22553F-25ug 25μg
EUR 31.5

APC Rat IgG2b, κ Isotype Control
DL22539F-20Tests 20Tests
EUR 170

APC Rat IgG2b, κ Isotype Control
DL22539F-50Tests 50Tests
EUR 245

APC Rat IgG2b, κ Isotype Control
DL22554F-25ug 25μg
EUR 147.5

APC Rat IgG2b, κ Isotype Control
DL22554F-50ug 50μg
EUR 197

APC Rat IgG2b, κ Isotype Control
JOT22539F 20Tests
EUR 154.7
Description: APC

APC Rat IgG2b, κ Isotype Control
JOT22554F 25μg
EUR 134.23
Description: APC

APC rat IgG2b, κ Isotype Control
E16FRCA003K-025U 25 μg
EUR 173.33
Description: Available in various conjugation types.

APC rat IgG2b, κ Isotype Control
E16FRCA003K-100U 100 μg
EUR 411.67
Description: Available in various conjugation types.

APC Rat IgG2b, κ Isotype Control
RD22539F-100Tests 100Tests
EUR 165

APC Rat IgG2b, κ Isotype Control
RD22539F-100Testsx2 100Testsx2
EUR 240

APC Rat IgG2b, κ Isotype Control
RD22539F-20Tests 20Tests
EUR 60

APC Rat IgG2b, κ Isotype Control
RD22554F-100ug 100μg
EUR 103.5

APC Rat IgG2b, κ Isotype Control
RD22554F-25ug 25μg
EUR 45

FITC Rat IgG2b, κ Isotype Control
DL22537F-20Tests 20Tests
EUR 158

FITC Rat IgG2b, κ Isotype Control
DL22537F-50Tests 50Tests
EUR 233

FITC Rat IgG2b, κ Isotype Control
DL22552F-25ug 25μg
EUR 137

FITC Rat IgG2b, κ Isotype Control
DL22552F-50ug 50μg
EUR 182

FITC Rat IgG2b, κ Isotype Control
JOT22537F 20Tests
EUR 143.78
Description: FITC

FITC Rat IgG2b, κ Isotype Control
JOT22552F 25μg
EUR 124.67
Description: FITC

FITC rat IgG2b, κ Isotype Control
E16FRCF003K-025 25 tests
EUR 130
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control
E16FRCF003K-050U 50 μg
EUR 151.67
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control
E16FRCF003K-100 100 tests
EUR 411.67
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control
E16FRCF003K-200U 200 μg
EUR 628.33
Description: Available in various conjugation types.

FITC Rat IgG2b, κ Isotype Control
RD22537F-100Tests 100Tests
EUR 123

FITC Rat IgG2b, κ Isotype Control
RD22537F-100Testsx2 100Testsx2
EUR 168

FITC Rat IgG2b, κ Isotype Control
RD22537F-20Tests 20Tests
EUR 48

FITC Rat IgG2b, κ Isotype Control
RD22552F-100ug 100μg
EUR 75

FITC Rat IgG2b, κ Isotype Control
RD22552F-25ug 25μg
EUR 31.5

PerCP Rat IgG2b, κ Isotype Control
DL22540F-20Tests 20Tests
EUR 185

PerCP Rat IgG2b, κ Isotype Control
DL22540F-50Tests 50Tests
EUR 267.5

AF488 Rat IgG2b, κ Isotype Control
DL22546F-20Tests 20Tests
EUR 185

AF488 Rat IgG2b, κ Isotype Control
DL22546F-50Tests 50Tests
EUR 267.5

AF647 Rat IgG2b, κ Isotype Control
DL22547F-20Tests 20Tests
EUR 185

AF647 Rat IgG2b, κ Isotype Control
DL22547F-50Tests 50Tests
EUR 267.5

PerCP Rat IgG2b, κ Isotype Control
DL22555F-25ug 25μg
EUR 182

PerCP Rat IgG2b, κ Isotype Control
DL22555F-50ug 50μg
EUR 272

AF488 Rat IgG2b, κ Isotype Control
DL22561F-25ug 25μg
EUR 182

AF488 Rat IgG2b, κ Isotype Control
DL22561F-50ug 50μg
EUR 272

AF647 Rat IgG2b, κ Isotype Control
DL22562F-25ug 25μg
EUR 182

AF647 Rat IgG2b, κ Isotype Control
DL22562F-50ug 50μg
EUR 272

PerCP Rat IgG2b, κ Isotype Control
JOT22540F 20Tests
EUR 168.35
Description: PerCP

AF488 Rat IgG2b, κ Isotype Control
JOT22546F 20Tests
EUR 168.35
Description: AF488

AF647 Rat IgG2b, κ Isotype Control
JOT22547F 20Tests
EUR 168.35
Description: AF647

PerCP Rat IgG2b, κ Isotype Control
JOT22555F 25μg
EUR 165.62
Description: PerCP

AF488 Rat IgG2b, κ Isotype Control
JOT22561F 25μg
EUR 165.62
Description: AF488

AF647 Rat IgG2b, κ Isotype Control
JOT22562F 25μg
EUR 165.62
Description: AF647

EV450 Rat IgG2b, κ Isotype Control
JOT22737F 20Tests
EUR 247.52
Description: EV450

EV450 Rat IgG2b, κ Isotype Control
JOT22749F 25μg
EUR 247.52
Description: EV450

ER780 Rat IgG2b, κ Isotype Control
JOT22810F 20Tests
EUR 247.52
Description: ER780

In this research, L-his and L-glu had been used to change the structural properties of HA in numerous experimental situations and buffer techniques (tris and hepes). The outcomes confirmed that L-his was in a position to regulate the plate-shaped morphology of HA in each experimental situation, in contrast to the L-glu, the place the crystal morphology was regulated by experimental situations. Both amino acids behaved in another way in DI water, tris, and hepes buffer, and the media used influenced the precipitation time and structural properties of HA.

Hepes and tris buffers additionally influenced the HA precipitation course of. Overall, the research revealed that L-his could also be used as an efficient regulator of plate-shaped morphology of HA, as a substitute of massive NCPs/proteins, for designing biomaterials for bone regeneration functions and the selection of buffer system is vital in designing and evaluating the techniques for mineralization. In cell tradition research, mouse osteoblast precursor cells (MC3T3-E1) confirmed highest proliferation on the bone-like plate-shaped HA, amongst all of the HA samples investigated.

In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

Violet Rodriguez

Poly(lactic acid) (PLA) and poly(ɛ-caprolactone) (PCL) are two necessary aliphatic esters identified for his or her biodegradability and bioresorbability properties; the previous is stiffer and brittle whereas the smaller modulus of the latter permits an appropriate elongation. The new biomaterials being developed from the blend of these two polymers (PLA and PCL) is opportune because of the decreasing interfacial stress between their immiscible phases. In a earlier research, PLA/PCL immiscible blend when compatibilized with poly(ε-caprolactone-b-tetrahydrofuran) resulted in enhanced ductility and toughness no cytotoxic impact in vitro exams. There is little printed knowledge on the impact of poly(ε-caprolactone-b-tetrahydrofuran) on PLA and PCL biocompatibility and biodegradability in vivo exams.

This research focuses on evaluating the behavioral response and polymer-tissue interplay of compatibilized PLA/PCL blend in comparison with neat PLA implanted by way of intraperitoneal (IP) and subcutaneous (SC) in male Wistar rats, distributed in 4 experimental teams: neat PLA, PLA/PCL blend, sham, and management at 2-, 8- and 24-weeks post-implantation (WPI). Open-field take a look at was carried out to appraise emotionality and spontaneous locomotor exercise. Histopathological investigation utilizing hematoxylin-eosin (H&E) and picrosirius-hematoxylin (PSH) was used to evaluate polymer-tissue interplay. Modifications in PLA and the PLA / PCL blend’s floor morphology have been decided by scanning electron microscopy (SEM).

PLA group defecated extra typically than PLA/PCL rats 2 and Eight WPI. Conjunctive capsule growth round implants, cell adhesion, angiogenesis, and big cells of a international physique to the biomaterial was noticed in gentle microscopy. Both teams displayed a fibrous response alongside with collagen deposition across the biomaterials. In the SEM, the photographs confirmed a better degradation price for the PLA/PCL blend in each implantation routes. The polymers implanted by way of IP exhibited a better degradation price in comparison with SC. These findings emphasize the biocompatibility of the PLA/PCL blend compatibilized with poly(ε-caprolactone-b-tetrahydrofuran), making this biopolymer an appropriate different in a range of biomedical applicatio.

Design issues for engineering 3D fashions to check vascular pathologies in vitro

Many cardiovascular ailments (CVD) are pushed by pathological remodelling of blood vessels, which might result in aneurysms, myocardial infarction, ischaemia and strokes. Aberrant remodelling is pushed by adjustments in vascular cell behaviours mixed with degradation, modification, or irregular deposition of extracellular matrix (ECM) proteins. The underlying mechanisms that drive the pathological remodelling of blood vessels are multifaceted and illness particular; nevertheless, unravelling them could also be key to growing therapies. Reductionist fashions of blood vessels created in vitro that mix cells with biomaterial scaffolds could function helpful analogues to check vascular illness development in a managed setting.
This evaluate presents the primary issues for growing such in vitro fashions. We talk about how the design of blood vessel fashions impacts experimental readouts, with a specific give attention to the upkeep of regular mobile phenotypes, methods that mimic regular cell-ECM interactions, and approaches that foster intercellular communication between vascular cell varieties. We additionally spotlight how selection of biomaterials, mobile preparations and the inclusion of mechanical stimulation utilizing fluidic gadgets collectively impression the flexibility of blood vessel fashions to imitate in vivo circumstances. In the longer term, by combining advances in supplies science, cell biology, fluidics and modelling, it might be attainable to create blood vessel fashions which are patient-specific and can be utilized to develop and take a look at therapies.
In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

Repair of segmental bone defect utilizing tissue engineered heterogeneous deproteinized bone doped with lithium

Lithium have been proven to play an necessary position in enhancing the osteogenic properties of biomaterials. This research goals to discover the osteogenic enchancment impact of tissue engineered heterogeneous deproteinized bone (HDPB) doped with lithium, and consider their effectiveness in the therapeutic of bone defects. Bone marrow mesenchymal stem cells (BMSCs) have been co-cultured with totally different focus of lithium chloride. Cell proliferation in every group was analyzed by 3-(4, 5-dimetyl-2-thiazoly-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay.

BMSCs have been then co-cultured in osteogenic induction medium with totally different focus of lithium chloride, and the expression of associated mRNA was detected. The position of lithium in selling BMSCs osteogenic differentiation and inhibiting BMSCs lipogenic differentiation was additionally investigated. Biomechanical properties of the tibia have been evaluated at Eight weeks after operation. The tibial specimens of every group have been collected at 4 and Eight weeks after surgical procedure for histological examination and histological evaluation.

Micro-computed tomography (CT) scanning and 3D reconstruction have been carried out at Eight weeks. The outcomes display that lithium can induce the osteogenic differentiation inhibit of adipogenic differentiation of BMSCs by regulating the Wnt signaling pathway. The histological analysis additional licensed that common bone formation space in the group of tissue engineered HDPB doped with lithium was additionally considerably higher than that of HDPB alone group. Based on the above analysis, tissue engineered HDPB doped with lithium can successfully promote the regeneration of segmental bone defect, which can be utilized as a tissue engineering scaffold for medical trials.

RFP Control Lentivirus (Neo)
LV058 4 x 500 ul
EUR 195

EF1a control lentivirus (Zeo)
EF1a-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.

RFP Control Lentivirus (Puro)
LV096 4 x 500 ul
EUR 195

CMV control lentivirus (Hygro)
CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

CAR negative control: CD28-CD3ζ (GFP-Puro) Lentivirus
CAR-ctr8 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

EF1a control lentivirus (Hygro)
EF1a-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

RFP (mRuby3) Control Lentivirus
LV101 4 x 500 ul
EUR 195

Scrambled shRNA Control Lentivirus
LSV-0024-1S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-2S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-3S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-4S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-5S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-6S 2x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-7S 2.5x10^6
EUR 395
Description: vsv-g

Scrambled shRNA Control Lentivirus
LSV-0024-8S 2.5x10^6
EUR 395
Description: vsv-g

CAR negative control: 4-1BB-CD3ζ (GFP-Puro) Lentivirus
CAR-ctr7 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (4-1BB) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

RFP (TagRFP-T) Control Lentivirus
LV097 4 x 500 ul
EUR 195

Negative Control Luciferase Lentivirus
79578 500 µl x 2
EUR 860
Description: The Negative Control Lentivirus (Firefly Luciferase) are replication incompetent, HIV-based, VSV-G pseudo typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of a minimal TATA promoter, without any additional transcriptional response elements.

CMV control lentivirus (No Selection)
CMV-Null- 1 x10^7 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus under CMV promoter, does not contain any antibiotic selection.

Expression Negative Control Lentivirus (G418)
79902-G 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

Expression Negative Control Lentivirus (Puromycin)
79902-P 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

Expression Negative Control Lentivirus (Hygromycin)
79902-H 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

CAR negative control: CD28-CD3ζ (No Select) Lentivirus
CAR-ctr6 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, does not contain any antibiotic selection

CMV Control (No Antibiotic), Concentrated Lentivirus in PBS
CMV-Null-PBS 1 x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Negative control lentivirus under CMV promoter, contains no any antibioic selection.

EF1a Control (No Antibiotic), Concentrated Lentivirus in PBS
EF1a-Null-PBS 1 x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Negative control lentivirus under EF1a promoter, contains no any antibioic selection.

CAR negative control: 4-1BB-CD3ζ (No Select) Lentivirus
CAR-ctr5 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (4-1BB) control lentivirus without targeting domain, do not any antibiotic selection

AR-RFP (GFP) Lentivirus 
LVP913-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AR-Luc (GFP) Lentivirus 
LVP914-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-RFP (GFP) Lentivirus 
LVP950-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-Luc (GFP) Lentivirus 
LVP951-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-RFP (GFP) Lentivirus 
LVP970-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-Luc (GFP) Lentivirus 
LVP971-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-RFP (GFP) Lentivirus 
LVP974-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-Luc (GFP) Lentivirus 
LVP975-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-RFP (GFP) Lentivirus 
LVP1022-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-Luc (GFP) Lentivirus 
LVP1023-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AR-Rluc (GFP) Lentivirus 
LVP915-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-RFP (GFP) Lentivirus 
LVP946-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-Luc (GFP) Lentivirus 
LVP947-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-Rluc (GFP) Lentivirus 
LVP952-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-RFP (GFP) Lentivirus 
LVP954-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-Luc (GFP) Lentivirus 
LVP955-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-RFP (GFP) Lentivirus 
LVP958-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-Luc (GFP) Lentivirus 
LVP959-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-RFP (GFP) Lentivirus 
LVP962-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-Luc (GFP) Lentivirus 
LVP963-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-Rluc (GFP) Lentivirus 
LVP972-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-Rluc (GFP) Lentivirus 
LVP976-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-RFP (GFP) Lentivirus 
LVP978-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-Luc (GFP) Lentivirus 
LVP979-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-RFP (GFP) Lentivirus 
LVP982-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-Luc (GFP) Lentivirus 
LVP983-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-RFP (GFP) Lentivirus 
LVP994-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-Luc (GFP) Lentivirus 
LVP995-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-Rluc (GFP) Lentivirus 
LVP1024-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-RFP (GFP) Lentivirus 
LVP1026-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-Luc (GFP) Lentivirus 
LVP1027-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-RFP (GFP) Lentivirus 
LVP1034-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-Luc (GFP) Lentivirus 
LVP1035-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-RFP (GFP) Lentivirus 
LVP1042-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-Luc (GFP) Lentivirus 
LVP1043-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-RFP (GFP) Lentivirus 
LVP1046-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-Luc (GFP) Lentivirus 
LVP1047-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ISRE-RFP (GFP) Lentivirus 
LVP938-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ISRE-Luc (GFP) Lentivirus 
LVP939-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-RFP (GFP) Lentivirus 
LVP942-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-Luc (GFP) Lentivirus 
LVP943-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-Rluc (GFP) Lentivirus 
LVP948-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-Rluc (GFP) Lentivirus 
LVP956-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-Rluc (GFP) Lentivirus 
LVP960-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-Rluc (GFP) Lentivirus 
LVP964-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-RFP (GFP) Lentivirus 
LVP966-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-Luc (GFP) Lentivirus 
LVP967-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-Rluc (GFP) Lentivirus 
LVP980-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-Rluc (GFP) Lentivirus 
LVP984-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-RFP (GFP) Lentivirus 
LVP986-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-Luc (GFP) Lentivirus 
LVP987-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-Rluc (GFP) Lentivirus 
LVP996-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-RFP (GFP) Lentivirus 
LVP998-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-Luc (GFP) Lentivirus 
LVP999-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD43-RFP (GFP) Lentivirus 
LVP1002-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD43-Luc (GFP) Lentivirus 
LVP1003-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-RFP (GFP) Lentivirus 
LVP1006-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-Luc (GFP) Lentivirus 
LVP1007-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-RFP (GFP) Lentivirus 
LVP1010-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-Luc (GFP) Lentivirus 
LVP1011-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-RFP (GFP) Lentivirus 
LVP1014-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-Luc (GFP) Lentivirus 
LVP1015-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-Rluc (GFP) Lentivirus 
LVP1028-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-RFP (GFP) Lentivirus 
LVP1030-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-Luc (GFP) Lentivirus 
LVP1031-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-Rluc (GFP) Lentivirus 
LVP1036-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-Rluc (GFP) Lentivirus 
LVP1044-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-Rluc (GFP) Lentivirus 
LVP1048-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-RFP (GFP) Lentivirus 
LVP1120-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains another fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-RFP (GFP) Lentivirus 
LVP1120-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express RFP reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains another fluorescent marker GFP under RSV promoter, provided in PBS solution.

EGR1-Luc (GFP) Lentivirus 
LVP1121-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Luc (GFP) Lentivirus 
LVP1121-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express Firefly Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in PBS solution.

GFAP-RFP (GFP) Lentivirus 
LVP1126-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-RFP (GFP) Lentivirus 
LVP1126-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express RFP reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

GFAP-Luc (GFP) Lentivirus 
LVP1127-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-Luc (GFP) Lentivirus 
LVP1127-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express Firefly luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter. Lentivirus concentrated and provided in PBS solution.

ISRE-Rluc (GFP) Lentivirus 
LVP940-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-Rluc (GFP) Lentivirus 
LVP944-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-Rluc (GFP) Lentivirus 
LVP968-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-Rluc (GFP) Lentivirus 
LVP988-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GATA2-RFP (GFP) Lentivirus 
LVP990-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under GATA-2 promoter which dynamically expressed in hematopoietic tissues and in the central nervous system. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GATA2-Luc (GFP) Lentivirus 
LVP991-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under GATA-2 promoter which dynamically expressed in hematopoietic tissues and in the central nervous system. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-Rluc (GFP) Lentivirus 
LVP1000-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter, carrying GFP reporter

CD43-Rluc (GFP) Lentivirus 
LVP1004-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-Rluc (GFP) Lentivirus 
LVP1008-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-Rluc (GFP) Lentivirus 
LVP1012-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-Rluc (GFP) Lentivirus 
LVP1016-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ICAM2-RFP (GFP) Lentivirus 
LVP1018-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under the human ICAM-2's promoter which expressed specifically in vasculature endothelial cells and megakaryocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ICAM2-Luc (GFP) Lentivirus 
LVP1019-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under the human ICAM-2's promoter which expressed specifically in vasculature endothelial cells and megakaryocytes. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-Rluc (GFP) Lentivirus 
LVP1032-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CCKAR-RFP (GFP) Lentivirus 
LVP1038-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express RFP reporter under human CCKR's promoter which is predominantly expressed in human pancreatic cancer. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CCKAR-Luc (GFP) Lentivirus 
LVP1039-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Firefly luciferase reporter under human CCKR's promoter which is predominantly expressed in human pancreatic cancer. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Rluc (GFP) Lentivirus 
LVP1122-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Rluc (GFP) Lentivirus 
LVP1122-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express Renilla Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in PBS solution.

GFAP-Rluc (GFP) Lentivirus 
LVP1128-G 1x107 IFU/ml x 200ul
EUR 346.5
Description: Pre-made lentivirus express Renilla luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-Rluc (GFP) Lentivirus 
LVP1128-G-PBS 1x108 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express Renilla luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

Complex coacervation permits necessary moist adhesion processes in pure and synthetic methods. However, existed artificial coacervate adhesives present restricted moist adhesion properties, non-thermoresponsiveness, and inferior biodegradability, drastically hampering their translations. Herein, by harnessing supramolecular meeting and rational protein design, we current a temperature-sensitive moist bioadhesive fabricated via recombinant protein and surfactant. Mechanical efficiency of the bioglue system is actively tunable with thermal triggers.